首页> 外文期刊>Nucleic Acids Research >METHYLATION INHIBITORS CAN INCREASE THE RATE OF CYTOSINE DEAMINATION BY (CYTOSINE-5)-DNA METHYLTRANSFERASE
【24h】

METHYLATION INHIBITORS CAN INCREASE THE RATE OF CYTOSINE DEAMINATION BY (CYTOSINE-5)-DNA METHYLTRANSFERASE

机译:甲基化抑制剂可提高(cytosine-5)-DNA甲基转移酶对胞嘧啶脱氨的速率

获取原文
获取原文并翻译 | 示例
           

摘要

The target cytosines of (cytosine-5)-DNA methyltransferases in prokaryotic and eukaryotic DNA show increased rates of C-->T transition mutations compared to non-target cytosines. These mutations are induced either by the spontaneous deamination of 5-mC-->T generating inefficiently repaired G:T rather than G:U mismatches, or by the enzyme-induced C-->U deamination which occurs under conditions of reduced levels of Sadenosylmethionine (AdoMet) and S-adenosylhomocysteine (AdoHcy). We tested whether various inhibitors of (cytosine-5)-DNA methyltransferases analogous to AdoMet and AdoHcy would affect the rate of enzyme-induced deamination of the target cytosine by M.Hpall and M.Sssl. Interestingly, we found two compounds, sinefungin and 5'-amino-5'-deoxyadenosine, that increased the rate of deamination 10(3)-fold in the presence and 10(4) fold in the absence of AdoMet and AdoHcy. We have therefore identified the first mutagenic compounds specific for the target sites of (cytosine-5)-DNA methyltransferases. A number of analogs of AdoMet and AdoHcy have been considered as possible antiviral, anticancer, antifungal and antiparasitic agents. Our findings show that chemotherapeutic agents with affinities to the cofactor binding pocket of (cytosine-5)-DNA methyltransferase should be tested for their potential mutagenic effects.
机译:与非靶标胞嘧啶相比,原核和真核DNA中(cytosine-5)-DNA甲基转移酶的靶标胞嘧啶显示C-> T过渡突变的发生率增加。这些突变是由5-mC-> T的自发脱氨基反应产生的,而修复的G:T效率低下,而不是由G:U错配引起的,或者是由酶诱导的C-> U脱氨作用所致,这种情况是在降低水平的条件下发生的。腺苷甲硫氨酸(AdoMet)和S-腺苷同型半胱氨酸(AdoHcy)。我们测试了各种类似于AdoMet和AdoHcy的(cytosine-5)-DNA甲基转移酶抑制剂是否会影响M.Hpall和M.Sssl酶诱导的目标胞嘧啶脱氨的速率。有趣的是,我们发现了两种化合物,西非芬净和5'-氨基-5'-脱氧腺苷,在存在AdoMet和AdoHcy的情况下,其脱氨速率提高了10(3)倍,而在没有AdoMet和AdoHcy的情况下,脱氨速率提高了10(4)倍。因此,我们确定了第一种特异性针对(cytosine-5)-DNA甲基转移酶靶位点的诱变化合物。人们认为AdoMet和AdoHcy的许多类似物可能是抗病毒药,抗癌药,抗真菌药和抗寄生虫药。我们的研究结果表明,应测试与(cytosine-5)-DNA甲基转移酶的辅因子结合袋具有亲和力的化学治疗剂的潜在诱变作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号